In this Section |
223152 Subsistence difficulty and health vulnerabilities among drug-using womenMonday, November 8, 2010
: 4:30 PM - 4:50 PM
Background: Unmet subsistence needs (eg., food, shelter) threaten health and social justice at a fundamental level. We examined the influence of unmet subsistence needs in a sample of poor, drug-using women in San Francisco.
Methods: Drug-using women (N=322) were recruited via respondent driven sampling. In a 5-item scale, participants rated frequency of difficulty meeting needs for food, shelter, personal hygiene, clothing and bathroom access. A score >15 on the 20-point scale was defined as frequent subsistence difficulty (FSD). Data were also collected regarding health care, experiences of violence and sexual risk behavior. Results: FSD was reported by 19% of participants. Women with FSD were more likely to be uninsured (51% vs. 37%, p=.04) and to lack a primary health care provider (62% vs. 47%, p=.03) than women with less frequent difficulty. Sexual assault in the past 6 months was more common among women with FSD (49% vs. 26%, p<.01), as was physical assault (49% vs. 31%, p<.01). Women with FSD reported a higher prevalence of unprotected vaginal sex with multiple partners (70% vs. 54%, p=.02) and trading sex for money or drugs (77% vs. 57%, p<.01) than women with less frequent difficulty. Drug treatment and emergency department utilization in the past 6 months did not vary by level of subsistence difficulty, nor did self-reported mental illness. Conclusions: Women with FSD had the poorest outcomes in terms of primary care access, sexual risk and violent victimization. Addressing basic needs is vital to reducing health risks among marginalized women.
Learning Areas:
Advocacy for health and health educationPublic health or related research Social and behavioral sciences Learning Objectives: Keywords: Women's Health, Poverty
Presenting author's disclosure statement:
Qualified on the content I am responsible for because: I am co-Investigator of the research study presented I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.
Back to: 3423.0: Marginalization and treatment of drug-using women
|